The University of Toronto and University of Vienna pharmacologist developed L-dopa, a precursor to dopamine that remains the most widely used therapy for Parkinson’s disease.

A device that illuminates and oxygenates blood outside of the body before pumping it back in removes the gas by freeing hemoglobin from CO.

The facility, focused on finding treatments for mental health disorders, will be the first of its kind in the US.

The federal government cautions that the drug can affect brain development in both teens and fetuses.

Two coauthors of a new study discuss their findings about nearly 170 facilities in the southwestern US selling unproven therapies—and what should be done about them.

The robotic catheter can guide its own movements within the heart of a live mammal to the site of a leaky valve replacement.

Imaging of the human brain reveals constellations of activity associated with conscious and unconscious states.

Primates receiving heart transplants from genetically engineered pigs have survived more than six months, a new study reveals.

Physician Peter Gøtzsche, a board member of the organization, has been an outspoken critic of certain vaccines and of the pharma industry in general.